Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institutionMAGAGNOLI, Massimo; CASTAGNA, Luca; BALZAROTTI, Monica et al.American journal of hematology. 2003, Vol 73, Num 4, pp 267-272, issn 0361-8609, 6 p.Article

Phase II Study of Imatinib in Advanced ChordomaSTACCHIOTTI, Silvia; LONGHI, Alessandra; SPREAFICO, Carlo et al.Journal of clinical oncology. 2012, Vol 30, Num 9, pp 914-920, issn 0732-183X, 7 p.Article

High-dose chemotherapy in poor-prognosis adult small round-cell tumors: Clinical and molecular results from a prospective studyBERTUZZI, Alexia; CASTAGNA, Luca; NOZZA, Andrea et al.Journal of clinical oncology. 2002, Vol 20, Num 8, pp 2181-2188, issn 0732-183XArticle

Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancerGRASSELLI, Giacomo; VIGANO, Lucia; PEROTTI, Antonella et al.Journal of clinical oncology. 2001, Vol 19, Num 8, pp 2222-2231, issn 0732-183XArticle